CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).
Publication
, Conference
Smith, EML; Pang, H; Cirrincione, C; Fleishman, SB; Paskett, ED; Fadul, CE; Knox, C; Shapiro, CL; Gilman, P; Canc, LGB
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 20, 2012
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
June 20, 2012
Volume
30
Issue
18
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S. B., Paskett, E. D., Fadul, C. E., … Canc, L. G. B. (2012). CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 30).
Smith, Ellen M Lavoie, Herbert Pang, Constance Cirrincione, Stewart Barry Fleishman, Electra D. Paskett, Camilo E. Fadul, Chetaye Knox, Charles L. Shapiro, Paul Gilman, and Leukemia Grp B. Canc. “CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 30, 2012.
Smith EML, Pang H, Cirrincione C, Fleishman SB, Paskett ED, Fadul CE, et al. CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN). In: JOURNAL OF CLINICAL ONCOLOGY. 2012.
Smith, Ellen M. Lavoie, et al. “CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).” JOURNAL OF CLINICAL ONCOLOGY, vol. 30, no. 18, 2012.
Smith EML, Pang H, Cirrincione C, Fleishman SB, Paskett ED, Fadul CE, Knox C, Shapiro CL, Gilman P, Canc LGB. CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN). JOURNAL OF CLINICAL ONCOLOGY. 2012.
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
June 20, 2012
Volume
30
Issue
18
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences